Dare Bioscience, Inc. Payments of Financing Costs
Dare Bioscience, Inc. (DARE) reported Payments of Financing Costs of $28.50 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2026-08-13
- Dare Bioscience, Inc. payments of financing costs for the quarter ending 2026-06-30 was $0.00.
- Dare Bioscience, Inc. payments of financing costs for the quarter ending 2026-03-31 was $28.50K.
- Dare Bioscience, Inc. payments of financing costs for the quarter ending 2025-06-30 was $0.00.
- Dare Bioscience, Inc. payments of financing costs for the quarter ending 2025-03-31 was $0.00.
- Dare Bioscience, Inc. payments of financing costs for fiscal 2025 was $321.69K, a 305.62% increase from fiscal 2024.
- Dare Bioscience, Inc. payments of financing costs for fiscal 2024 was $79.31K.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 12 month |
|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $28.50K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $28.50K 10-Q · filed 2026-05-14 | ||
| 2025-12-31 | $321.69K 10-K · filed 2026-03-26 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | ||
| 2024-12-31 | $79.31K 10-K · filed 2026-03-26 | ||
| 2015-03-31 | $19.00K 10-Q · filed 2016-05-02 | ||
| 2014-03-31 | $1.06M 10-Q · filed 2015-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |